MKM Partners analyst Terry Kuittinen on Friday issued a note to investors reiterating a Buy rating on Motorola Mobility stock, setting the firm’s price target at $35. Kuittinen states that Motorola will likely see success with British carrier Orange, which launched Motorola’s new ATRIX smartphone ahead of upcoming competitors like the Samsung Galaxy S II and the LG Optimus 2X. The analyst also noted that the ATRIX is getting strong promotional backing elsewhere from carriers like TIM. In the U.S., Kuittinen thinks the delayed launch of Motorola’s upcoming DROID BIONIC won’t have much of an impact on the company’s sales, considering the higher pricing of 4G LTE phones like the LG Revolution, HTC ThunderBolt and Samsung DROID Charge. Motorola’s upcoming $200 DROID X2 will be a winner at Verizon Wireless, the analyst believes, and it could help Motorola sell 500,000 phones through Verizon this quarter.
MKM: Motorola may still sell 500,000 Verizon phones in Q2 despite DROID BIONIC delay
Updated Dec 19th, 2018 7:14PM EST
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs.
This article talks about:
3G 4G Android DROID Bionic estimates evdo LTE Motorola Motorola Mobility Sales Shipments Smartphones Verizon verizon wireless VZW
Zach Epstein has been the Executive Editor at BGR for more than 15 years. He manages BGR’s editorial team and ensures that best practices are adhered to. He also oversees the Ecommerce team and directs the daily flow of all content. Zach first joined BGR in 2007 as a Staff Writer covering business, technology, and entertainment.
His work has been quoted by countless top news organizations, and he was recently named one of the world's top 10 “power mobile influencers” by Forbes. Prior to BGR, Zach worked as an executive in marketing and business development with two private telcos.
More
Latest News
